Arphra/Issuer/COHANCE.BO

COHANCE.BO

Cohance Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →

$430.40

Jun 02, 2026

AI Brief

Revenue · FY

$22.69B

Net income

$1.79B

FY 2026

EPS · diluted

$4.68

EBITDA

$4.27B

Explain this page

Arphra AIPlain-English read on Cohance Lifesciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$430.40

Change

+16.32%

Period high

$488.30

Period low

$279.75

Period start

$370.002026-02-01

Through 2026-06-02

Peers

No peer list available for COHANCE.BO.

Sector & industry today

Live

Sectors

Healthcare
+1.73%
Financial Services
+1.62%
Industrials
+1.19%
Real Estate
+0.90%
Energy
+0.89%
Consumer Defensive
+0.65%
Consumer Cyclical
+0.59%
Basic Materials
+0.06%
Utilities
-0.53%
Technology
-1.85%
Communication Services
-2.33%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.88%
Investment - Banking & Investment Services
-4.27%
Broadcasting
-4.14%
Rental & Leasing Services
+4.02%
Software - Infrastructure
-3.76%
Software - Application
-3.71%
Electronic Gaming & Multimedia
-3.27%
Internet Content & Information
-3.02%
Auto - Recreational Vehicles
+2.96%
Computer Hardware
-2.88%
Financial - Mortgages
-2.86%
Solar
-2.84%

Fair value

Football field →

Weighted blend

$99.03

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Total assets

$57.3B

Total debt

$4B

Cash & equiv

$596.6M

Operating CF

$3.55B

Free cash flow

$1.35B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for COHANCE.BO.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$22.69B	$2.4B	$1.79B	$4.68	+7.90%